208 related articles for article (PubMed ID: 1998338)
1. Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15.
Phaneuf D; Labelle Y; Bérubé D; Arden K; Cavenee W; Gagné R; Tanguay RM
Am J Hum Genet; 1991 Mar; 48(3):525-35. PubMed ID: 1998338
[TBL] [Abstract][Full Text] [Related]
2. Cloning and expression analysis of a cDNA encoding fumarylacetoacetate hydrolase: post-transcriptional modulation in rat liver and kidney.
Labelle Y; Phaneuf D; Tanguay RM
Gene; 1991 Aug; 104(2):197-202. PubMed ID: 1916290
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity.
Labelle Y; Phaneuf D; Leclerc B; Tanguay RM
Hum Mol Genet; 1993 Jul; 2(7):941-6. PubMed ID: 8364576
[TBL] [Abstract][Full Text] [Related]
4. Structural organization and analysis of the human fumarylacetoacetate hydrolase gene in tyrosinemia type I.
Awata H; Endo F; Tanoue A; Kitano A; Nakano Y; Matsuda I
Biochim Biophys Acta; 1994 May; 1226(2):168-72. PubMed ID: 8204664
[TBL] [Abstract][Full Text] [Related]
5. Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I).
Tanguay RM; Valet JP; Lescault A; Duband JL; Laberge C; Lettre F; Plante M
Am J Hum Genet; 1990 Aug; 47(2):308-16. PubMed ID: 2378356
[TBL] [Abstract][Full Text] [Related]
6. Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.
Phaneuf D; Lambert M; Laframboise R; Mitchell G; Lettre F; Tanguay RM
J Clin Invest; 1992 Oct; 90(4):1185-92. PubMed ID: 1401056
[TBL] [Abstract][Full Text] [Related]
7. Correction of fumarylacetoacetate hydrolase deficiency (type I tyrosinemia) in cultured human fibroblasts by retroviral-mediated gene transfer.
Phaneuf D; Hadchouel M; Tanguay RM; Bréchot C; Ferry N
Biochem Biophys Res Commun; 1995 Mar; 208(3):957-63. PubMed ID: 7702626
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide sequence of a cDNA encoding murine fumarylacetoacetate hydrolase.
Grompe M; al-Dhalimy M
Biochem Med Metab Biol; 1992 Aug; 48(1):26-31. PubMed ID: 1524868
[TBL] [Abstract][Full Text] [Related]
9. Purification of mRNA coding for the enzyme deficient in hereditary tyrosinemia, fumarylacetoacetate hydrolase.
Nicole LM; Valet JP; Laberge C; Tanguay RM
Biochem Cell Biol; 1986 May; 64(5):489-93. PubMed ID: 3718716
[TBL] [Abstract][Full Text] [Related]
10. Localization of cells in the rat brain expressing fumarylacetoacetate hydrolase, the deficient enzyme in hereditary tyrosinemia type 1.
Labelle Y; Puymirat J; Tanguay RM
Biochim Biophys Acta; 1993 Jan; 1180(3):250-6. PubMed ID: 8422430
[TBL] [Abstract][Full Text] [Related]
11. Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
Aponte JL; Sega GA; Hauser LJ; Dhar MS; Withrow CM; Carpenter DA; Rinchik EM; Culiat CT; Johnson DK
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):641-5. PubMed ID: 11209059
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice.
Ruppert S; Kelsey G; Schedl A; Schmid E; Thies E; Schütz G
Genes Dev; 1992 Aug; 6(8):1430-43. PubMed ID: 1644288
[TBL] [Abstract][Full Text] [Related]
13. Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.
St-Louis M; Leclerc B; Laine J; Salo MK; Holmberg C; Tanguay RM
Hum Mol Genet; 1994 Jan; 3(1):69-72. PubMed ID: 8162054
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.
Overturf K; al-Dhalimy M; Ou CN; Finegold M; Tanguay R; Lieber A; Kay M; Grompe M
Hum Gene Ther; 1997 Mar; 8(5):513-21. PubMed ID: 9095403
[TBL] [Abstract][Full Text] [Related]
15. Murine fumarylacetoacetate hydrolase (Fah) gene is disrupted by a neonatally lethal albino deletion that defines the hepatocyte-specific developmental regulation 1 (hsdr-1) locus.
Klebig ML; Russell LB; Rinchik EM
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1363-7. PubMed ID: 1741389
[TBL] [Abstract][Full Text] [Related]
16. Cloning and expression of fumarylacetoacetate hydrolase derived from marine yeast Rhodosporidium diobovatum.
Liu Y; Xia W; Yang P; Zhang S; Shi Z; Tang H; Zhang L
J Basic Microbiol; 2015 Sep; 55(9):1082-93. PubMed ID: 25832819
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1.
Bergeron A; D'Astous M; Timm DE; Tanguay RM
J Biol Chem; 2001 May; 276(18):15225-31. PubMed ID: 11278491
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I.
Grompe M; al-Dhalimy M
Hum Mutat; 1993; 2(2):85-93. PubMed ID: 8318997
[TBL] [Abstract][Full Text] [Related]
19. Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1.
Li L; Zhang Q; Yang H; Zou Q; Lai C; Jiang F; Zhao P; Luo Z; Yang J; Chen Q; Wang Y; Newsome PN; Frampton J; Maxwell PH; Li W; Chen S; Wang D; Siu TS; Tam S; Tse HF; Qin B; Bao X; Esteban MA; Lai L
J Biol Chem; 2017 Mar; 292(11):4755-4763. PubMed ID: 28053091
[TBL] [Abstract][Full Text] [Related]
20. Rescue of mice homozygous for lethal albino deletions: implications for an animal model for the human liver disease tyrosinemia type 1.
Kelsey G; Ruppert S; Beermann F; Grund C; Tanguay RM; Schütz G
Genes Dev; 1993 Dec; 7(12A):2285-97. PubMed ID: 8253377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
